Urgent.News

What's breaking now, across thousands of outlets.

Science

Dual-purpose polymer dots could combine bioimaging and light-triggered cell death in one material

A research team led by professor Youhei Takeda at the University of Osaka, in collaboration with professor Zachary M. Hudson at the University of British Columbia (UBC) in Canada, has developed a polymer material that combines fluorescent cell imaging with the potential to kill cancer cells when activated by light. The material could offer a simpler approach to developing "nanotheranostic"…

Dual-purpose polymer dots could combine bioimaging and light-triggered cell death in one material

Researchers at Osaka University and the University of British Columbia have developed a single polymer material that can serve both as a bio-imaging tool and a potential cancer-killing agent. This dual-purpose polymer, known as a nanotheranostic, could simplify the development of future technologies that combine disease imaging and treatment in one platform.

The polymer, formed into nanoparticles called polymer dots, emits fluorescent light for imaging purposes while also generating singlet oxygen, which can damage and kill cells. This dual functionality is made possible through a process called thermally activated delayed fluorescence (TADF). The delayed fluorescence lasts much longer than the background glow of cells and tissue, enabling clearer, higher-contrast imaging.

Under specific light-irradiation conditions, the polymer can also generate singlet oxygen, paving the way for photodynamic therapy, a technique that uses light-activated chemical processes to damage targeted cells. The polymer's distinctive properties stem from through-space charge transfer, where electronic interactions occur between molecular groups in close proximity, rather than through the chemical bonds linking them.

This structure, known as conformational adaptability, prevents the loss of light emission that typically occurs when light-emitting molecules are crowded together.

One advantage of this combined approach is that it eliminates the need for a separate light-activated compound, or photosensitizer, which is often required in other imaging-therapy integration methods. This integration could simplify the design process for future applications that link imaging and therapy.

The material's performance in water, which mimics the body's environment, was also tested. The researchers found that the polymer retained its orange emission and long-lived delayed fluorescence even with a high proportion of light-emitting units, demonstrating its potential for use in biological systems.

The study, published in Chem & Bio Engineering, highlights the importance of international collaboration. The research team, led by professor Youhei Takeda at Osaka University, conducted experiments at the University of British Columbia in Canada, supported by Japan's JST-ASPIRE program. The researchers believe that this collaboration could accelerate the development of advanced luminescent materials for future biomedical applications.

Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at phys.org →

More in Science

More from Thursday 19 November →